|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Investments at fair value: | |||||||||
| Non-control/non-affiliate Investments | |||||||||
| Affiliate Investments | |||||||||
| Total investments at fair value | |||||||||
| Cash and cash equivalents | |||||||||
| Interest and dividend receivable | |||||||||
| Prepaid expenses | |||||||||
| Receivable for unsettled trades | |||||||||
| Distribution paid in advance to transfer agent | |||||||||
| Other assets | |||||||||
| Total assets | |||||||||
| LIABILITIES | |||||||||
| 2026 Notes (net of deferred financing costs and original issue discount of $1,147 and $1,421, respectively) | |||||||||
| 2026 Notes | |||||||||
| Total 2026 Notes (net of deferred financing costs and original issue discount of $1,147 and $1,421, respectively) | |||||||||
| 2026 Notes (net of deferred financing costs and original issue discount of $602 and $694, respectively) | |||||||||
| 2032 Convertible Notes (net of deferred financing costs and original issue discount of $283 and $439, respectively) | |||||||||
| 2032 Convertible Notes | |||||||||
| Total 2032 Convertible Notes (net of deferred financing costs and original issue discount of $283 and $439, respectively) | |||||||||
| KeyBank Credit Facility (net of deferred financing costs of $1,092 and $1,147, respectively) | |||||||||
| KeyBank Credit Facility | |||||||||
| Total keyBank Credit Facility (net of deferred financing costs of $1,092 and $1,147, respectively) | |||||||||
| Management and incentive fees payable | |||||||||
| Distribution payable | |||||||||
| Interest and financing fees payable | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Payable for unsettled trades | |||||||||
| Total liabilities | |||||||||
| NET ASSETS | |||||||||
| Common stock, par value $0.01, 100,000,000 shares of common stock authorized, 2,655,973 and 2,655,898 shares of common stock issued and outstanding, respectively | |||||||||
| Capital in excess of par value | |||||||||
| Total distributable loss | |||||||||
| Total net assets | |||||||||
| Total liabilities and net assets | |||||||||
| Net asset value per share |
Loading...
